| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | President &CSO
1 company
Shacham Sharon is a Chief Scientific Officer at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $8.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 7, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $16.77 | $167,747.00 | -1.4% | |
| Apr 18, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $14.79 | $147,878.00 | -1.9% | |
| Apr 9, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $12.48 | $124,829.00 | -1.4% | |
| Mar 19, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $15.29 | $152,895.00 | -1.9% | |
| Mar 7, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $16.15 | $161,463.00 | -1.4% | |
| Feb 20, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $14.79 | $147,872.00 | -1.9% | |
| Feb 7, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $12.50 | $125,048.00 | -1.4% | |
| Jan 18, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $10.09 | $100,882.00 | -1.9% | |
| Jan 8, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $10.08 | $100,769.00 | -1.4% | |
| Dec 18, 2017 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $9.16 | $91,553.00 | -1.9% |